Ketotifen Unit Dose Stulln

Ketotifen, the active ingredient in Ketotifen Unit Dose Stulln, is an antihistamine presented as a unit‑dose ophthalmic preparation for ocular use. It is used to relieve ocular allergy symptoms such as itching, redness and swelling in patients with allergic eye disease.

GNH USA supplies Ketotifen Unit Dose Stulln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketotifen acts on ocular allergic pathways to control inflammation and histamine‑mediated symptoms.

Allergic conjunctivitis: reduces itching, redness and tearing associated with seasonal or perennial eye allergies. Vernal keratoconjunctivitis: helps control chronic inflammation and photophobia in this severe allergic eye condition. Contact lens‑related allergy: alleviates discomfort when lenses exacerbate allergic responses.

Ketotifen is generally well tolerated, but ocular and systemic reactions can occur.

Common Side Effects: - Transient burning or stinging sensation after instillation. - Mild eye irritation or foreign‑body feeling. - Temporary blurred vision. - Mild headache. - Dry eye sensation. - Slight reddening of the conjunctiva.

Serious or Rare Side Effects: - Severe allergic reaction (angio‑edema, anaphylaxis). - Corneal ulceration or epithelial defect. - Persistent eye pain or photophobia. - Sudden loss of vision. - Significant intra‑ocular pressure rise. - Systemic hypersensitivity (rash, fever).

Ketotifen should be used with caution in certain situations.

Hypersensitivity: avoid if known allergy to ketotifen or any formulation component. Pediatric use: consult an ophthalmologist before treating children. Infection: do not use if active ocular infection is present. Contact lenses: remove lenses before instillation and wait before reinserting. Driving: avoid operating machinery if blurred vision occurs. Store at ambient temperature: keep in original container, protect from moisture and light.

Ketotifen may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concurrent use with other mast‑cell stabilisers may increase ocular irritation. - Combination with topical anesthetics can potentiate corneal toxicity.

Moderate Interactions (Monitor Closely): - Systemic antihistamines may enhance sedative effects. - Topical corticosteroids may mask signs of infection. - Ocular decongestants may alter ketotifen absorption. - Use with other antihistamine eye drops may increase risk of dry eye. - Alcohol consumption may exacerbate transient headache.